Detalles de la búsqueda
1.
Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy-a sub-analysis of the ALTTO study.
Br J Cancer
; 127(10): 1799-1807, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36050448
2.
Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project.
Mod Pathol
; 35(12): 1888-1899, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36115922
3.
Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays' and cross-validation with resections, in patients with, stage I-III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort.
Mod Pathol
; 33(5): 792-801, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31740722
4.
Correction to: Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project.
Mod Pathol
; 35(12): 2033, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36253399
5.
Assessment of RANK/RANK-L prevalence and clinical significance in NSCLC European Thoracic Oncology Platform Lungscape cohort and SPLENDOUR randomized clinical trial.
Lung Cancer
; 175: 141-151, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36535121
6.
A phase 1 trial of adoptive transfer of vaccine-primed autologous circulating T cells in ovarian cancer.
Nat Cancer
; 4(10): 1410-1417, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37735588
7.
A prognostic score for patients with malignant pleural mesothelioma (MPM) receiving second-line immunotherapy or chemotherapy in the ETOP 9-15 PROMISE-meso phase III trial.
Lung Cancer
; 169: 77-83, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35660972
8.
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy.
Cancer Discov
; 12(1): 108-133, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34479871
9.
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries.
J Immunother Cancer
; 10(11)2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36450384
10.
SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.
BMJ Open
; 11(7): e049232, 2021 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34226231
11.
Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC - The ETOP/EORTC SPLENDOUR and AMGEN-249 trials.
Lung Cancer
; 161: 76-85, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34543941
12.
Progression-Free and Overall Survival for Concurrent Nivolumab With Standard Concurrent Chemoradiotherapy in Locally Advanced Stage IIIA-B NSCLC: Results From the European Thoracic Oncology Platform NICOLAS Phase II Trial (European Thoracic Oncology Platform 6-14).
J Thorac Oncol
; 16(2): 278-288, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33188912
13.
Evolution and Clinical Impact of EGFR Mutations in Circulating Free DNA in the BELIEF Trial.
J Thorac Oncol
; 15(3): 416-425, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31812754
14.
Breast Cancer Statistics in the European Union: Incidence and Survival across European Countries.
Breast Care (Basel)
; 14(6): 344-353, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31933579
15.
Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysis.
Lung Cancer
; 134: 127-140, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31319971
16.
Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP).
J Thorac Oncol
; 14(6): 1086-1094, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30825613
17.
Psychometric Properties of the Revised Death Attitude Profile in a Greek Sample of Nurses.
J Nurs Meas
; 26(2): 264-277, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30567944
18.
Report on the status of women occupying leadership roles in oncology.
ESMO Open
; 3(6): e000423, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30273418
19.
Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey.
ESMO Open
; 3(6): e000422, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30273420
20.
Exploratory Analysis of Single-Gene Predictive Biomarkers in HERA DASL Cohort Reveals That C8A mRNA Expression Is Prognostic of Outcome and Predictive of Benefit of Trastuzumab.
JCO Precis Oncol
; 22018.
Artículo
en Inglés
| MEDLINE | ID: mdl-32913993